Vanda Pharmaceuticals Announces Presentations at SLEEP 2022

Rhea-AI Summary

Vanda Pharmaceuticals (Nasdaq: VNDA) announced its participation in the SLEEP 2022 conference in Charlotte, North Carolina, from June 4-8, 2022. On June 7, scientific presentations will focus on topics such as genetic aberrations linked to sleep disturbances and observational studies on sleep-wake phase disorders. Key presentations by Dr. Sandra Paulina Smieszek will include a novel missense variant in Melanopsin associated with delayed sleep. Vanda aims to develop innovative therapies for unmet medical needs.

Positive

• Participation in SLEEP 2022 highlights Vanda's commitment to research in sleep disorders.
• Presentations by leading researchers may enhance Vanda's reputation in the biopharmaceutical sector.

Negative

• None.

WASHINGTON, May 31, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at SLEEP 2022, to be held in Charlotte, North Carolina from June 4-8, 2022.

The following scientific posters will be presented:

June 7, 2022

Presenter: Dr. Sandra Paulina Smieszek, Head of Genetics
Poster Session Presentation Time: 5:15 PM – 7:15 PM ET

Title: "Enrichment of RAI1 genetic aberrations associated with sleep disturbances in SMS, in Autism Spectrum Disorder"  
Poster Number: 007

Title: "A 10-week observational research study in individuals with delayed sleep-wake phase disorder (DSWPD) symptoms"
Poster Number: 028

Title: "A novel missense variant in Melanopsin associates with delayed sleep phenotype: whole-genome sequencing study"  
Poster Number: 285

For more information on SLEEP 2022, please refer to https://www.sleepmeeting.org/.

About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on Twitter @vandapharma.

Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com 

Elizabeth Van Every
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com 

View original content:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-presentations-at-sleep-2022-301558351.html

SOURCE Vanda Pharmaceuticals Inc.

FAQ

What will Vanda Pharmaceuticals present at SLEEP 2022?

Vanda Pharmaceuticals will present scientific posters on June 7, 2022, focusing on genetic aberrations associated with sleep disturbances and a novel missense variant in Melanopsin.

When is SLEEP 2022 conference taking place?

The SLEEP 2022 conference will be held from June 4-8, 2022, in Charlotte, North Carolina.

Who is presenting for Vanda Pharmaceuticals at SLEEP 2022?

Dr. Sandra Paulina Smieszek, Head of Genetics, will present Vanda's posters at the SLEEP 2022 conference.

What is the focus of Vanda Pharmaceuticals' research presented at SLEEP 2022?

The research presented will focus on sleep disturbances, delayed sleep-wake phase disorder, and genetic factors affecting sleep.

How can I find more information about SLEEP 2022?

More information about SLEEP 2022 can be found on their official website at www.sleepmeeting.org.